On Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) was -2.19% drop from the session before settling in for the closing price of $5.93. A 52-week range for TERN has been $4.32 – $11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 6.25%. With a float of $62.28 million, this company’s outstanding shares have now reached $84.92 million.
The firm has a total of 66 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Terns Pharmaceuticals Inc stocks. The insider ownership of Terns Pharmaceuticals Inc is 26.68%, while institutional ownership is 71.52%. The most recent insider transaction that took place on Dec 05 ’24, was worth 110,468. In this transaction Chief Executive Officer of this company bought 15,450 shares at a rate of $7.15, taking the stock ownership to the 19,099 shares. Before that another transaction happened on Sep 12 ’24, when Company’s Director bought 476,190 for $10.50, making the entire transaction worth $4,999,995. This insider now owns 476,190 shares in total.
Terns Pharmaceuticals Inc (TERN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.25% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
You can see what Terns Pharmaceuticals Inc (TERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 32.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Analysing the last 5-days average volume posted by the [Terns Pharmaceuticals Inc, TERN], we can find that recorded value of 2.66 million was better than the volume posted last year of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 23.56%. Additionally, its Average True Range was 0.47.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 5.72%, which indicates a significant decrease from 19.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.91% in the past 14 days, which was higher than the 79.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.63, while its 200-day Moving Average is $7.02. Now, the first resistance to watch is $5.92. This is followed by the second major resistance level at $6.05. The third major resistance level sits at $6.16. If the price goes on to break the first support level at $5.68, it is likely to go to the next support level at $5.57. Should the price break the second support level, the third support level stands at $5.44.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are 84,939K outstanding shares of the company, which has a market capitalization of 492.65 million. As of now, sales total 0 K while income totals -90,210 K. Its latest quarter income was 0 K while its last quarter net income were -21,950 K.
